Jane Street Group, LLC Ac Immune Sa Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.66 - $4.87 $38,351 - $70,215
14,418 New
14,418 $42,000
Q4 2022

Feb 14, 2023
BUY
$1.72 - $3.12 $73,239 - $132,852
42,581 New
42,581 $86,000
Q2 2019

Aug 15, 2019
SELL
$4.72 - $5.88 $52,467 - $65,362
-11,116 Closed
0 $0
Q1 2019

May 16, 2019
BUY
$3.65 - $11.68 $40,573 - $129,834
11,116 New
11,116 $56,000

Others Institutions Holding ACIU

# of Institutions
47
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $224M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email